---
layout: post
title: "Health Care Sector Daily Brief: Top Market News for 2026-01-11"
date: "2026-01-11"
sector: "Health Care"
etf: "XLV"
description: "Today's Health Care sector headlines: 3 stories covering this, republicans, year, obesity, deals. Free daily market intelligence for investors."
keywords: "Health Care, XLV, stock market news, sector news, 2026-01-11, market intelligence, investing news"
og_title: "Health Care Daily Brief — 2026-01-11"
og_description: "3 breaking stories in Health Care: Key deals this week: Merck, Glencore, CrowdStrike,..., Trump faces headwinds on Venezuela, health care as..., 2026 is the year of obesity pills. Here's how they..."
permalink: /2026-01-11/health-care/
---

# Health Care Sector Daily Brief
## 2026-01-11 — 3 Stories

**Today's highlights:** this, republicans, year, obesity, deals

---

### 1. Key deals this week: Merck, Glencore, CrowdStrike, Marvell Technology, Steel Dynamics and more

**Source:** [Seeking Alpha (Market News)](https://seekingalpha.com/news/4538194-key-deals-this-week-merck-glencore-crowdstrike-marvell-technology-steel-dynamics-and-more?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news) · 2026-01-10

[Read full article →](https://seekingalpha.com/news/4538194-key-deals-this-week-merck-glencore-crowdstrike-marvell-technology-steel-dynamics-and-more?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news)

---

### 2. Trump faces headwinds on Venezuela, health care as some Republicans break rank

**Source:** [CNBC Top News](https://www.cnbc.com/2026/01/10/trump-venezuela-congress-republicans.html) · 2026-01-10
> A White House official said Republicans breaking with the president represent a "tiny fraction" of the congressional GOP.

[Read full article →](https://www.cnbc.com/2026/01/10/trump-venezuela-congress-republicans.html)

---

### 3. 2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market

**Source:** [CNBC Top News](https://www.cnbc.com/2026/01/10/2026-is-the-year-of-obesity-pills-from-novo-nordisk-eli-lilly-.html) · 2026-01-10
> Patients can already access the first GLP-1 obesity pill from Novo Nordisk, and a rival oral drug from Eli Lilly is slated for U.S. approval later this year.

[Read full article →](https://www.cnbc.com/2026/01/10/2026-is-the-year-of-obesity-pills-from-novo-nordisk-eli-lilly-.html)

---


## About This Brief

This daily Health Care sector intelligence brief is auto-generated from 9+ trusted financial news sources. Updated every morning at 8 AM UTC.

**Related:** [View all sectors for 2026-01-11](/2026-01-11/) | [Subscribe via RSS](/feed.xml)
